New York State Common Retirement Fund’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,065
| Closed | -$1K | – | 3530 |
|
|
2022
Q2 | $1K | Sell |
1,065
-108,878
| -99% | -$96K | ﹤0.01% | 3451 |
|
|
2022
Q1 | $142K | Buy |
109,943
+87
| +0.1% | +$80 | ﹤0.01% | 2940 |
|
|
2021
Q4 | $140K | Sell |
109,856
-206
| -0.2% | -$368 | ﹤0.01% | 2991 |
|
|
2021
Q3 | $240K | Buy |
110,062
+376
| +0.3% | +$1.03K | ﹤0.01% | 2843 |
|
|
2021
Q2 | $411K | Buy |
109,686
+1,186
| +1% | +$4.12K | ﹤0.01% | 2705 |
|
|
2021
Q1 | $354K | Hold |
108,500
| – | – | ﹤0.01% | 2616 |
|
|
2020
Q4 | $370K | Buy |
108,500
+3,100
| +3% | +$12.8K | ﹤0.01% | 2496 |
|
|
2020
Q3 | $430K | Hold |
105,400
| – | – | ﹤0.01% | 2277 |
|
|
2020
Q2 | $356K | Buy |
105,400
+32,300
| +44% | +$94.1K | ﹤0.01% | 2387 |
|
|
2020
Q1 | $170K | Sell |
73,100
-27,500
| -27% | -$75.3K | ﹤0.01% | 2538 |
|
|
2019
Q4 | $366K | Sell |
100,600
-13,500
| -12% | -$109K | ﹤0.01% | 2449 |
|
|
2019
Q3 | $946K | Hold |
114,100
| – | – | ﹤0.01% | 2020 |
|
|
2019
Q2 | $982K | Buy |
114,100
+12,700
| +13% | +$114K | ﹤0.01% | 2028 |
|
|
2019
Q1 | $1.08M | Hold |
101,400
| – | – | ﹤0.01% | 1924 |
|
|
2018
Q4 | $887K | Sell |
101,400
-8,800
| -8% | -$112K | ﹤0.01% | 1978 |
|
|
2018
Q3 | $1.85M | Hold |
110,200
| – | – | ﹤0.01% | 1732 |
|
|
2018
Q2 | $2.31M | Buy |
110,200
+14,700
| +15% | +$272K | ﹤0.01% | 1607 |
|
|
2018
Q1 | $1.54M | Buy |
95,500
+2,700
| +3% | +$53.5K | ﹤0.01% | 1772 |
|
|
2017
Q4 | $1.76M | Buy |
92,800
+12,300
| +15% | +$223K | ﹤0.01% | 1715 |
|
|
2017
Q3 | $1.13M | Hold |
80,500
| – | – | ﹤0.01% | 1943 |
|
|
2017
Q2 | $600K | Buy |
80,500
+13,099
| +19% | +$85.6K | ﹤0.01% | 2315 |
|
|
2017
Q1 | $438K | Buy |
67,401
+6,101
| +10% | +$34.1K | ﹤0.01% | 2446 |
|
|
2016
Q4 | $272K | Hold |
61,300
| – | – | ﹤0.01% | 2661 |
|
|
2016
Q3 | $286K | Hold |
61,300
| – | – | ﹤0.01% | 2608 |
|
|
2016
Q2 | $403K | Hold |
61,300
| – | – | ﹤0.01% | 2364 |
|
|
2016
Q1 | $390K | Hold |
61,300
| – | – | ﹤0.01% | 2352 |
|
|
2015
Q4 | $370K | Hold |
61,300
| – | – | ﹤0.01% | 2451 |
|
|
2015
Q3 | $367K | Sell |
61,300
-58,110
| -49% | -$403K | ﹤0.01% | 2463 |
|
|
2015
Q2 | $817K | Buy |
119,410
+11,410
| +11% | +$72.4K | ﹤0.01% | 2292 |
|
|
2015
Q1 | $656K | Hold |
108,000
| – | – | ﹤0.01% | 1974 |
|
|
2014
Q4 | $748K | Hold |
108,000
| – | – | ﹤0.01% | 1899 |
|
|
2014
Q3 | $879K | Sell |
108,000
-8,100
| -7% | -$63.4K | ﹤0.01% | 1891 |
|
|
2014
Q2 | $944K | Sell |
116,100
-4,000
| -3% | -$30.3K | ﹤0.01% | 1876 |
|
|
2014
Q1 | $942K | Hold |
120,100
| – | – | ﹤0.01% | 1846 |
|
|
2013
Q4 | $1.06M | Hold |
120,100
| – | – | ﹤0.01% | 1807 |
|
|
2013
Q3 | $1.01M | Hold |
120,100
| – | – | ﹤0.01% | 1752 |
|
|
2013
Q2 | $896K | Buy |
+120,100
| New | +$921K | ﹤0.01% | 1660 |
|
Other funds holding SPPI
AC
New York State Common Retirement Fund's SPPI Position: Q3 2022 in Review
New York State Common Retirement Fund sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2022, closing a stake of 1,065 shares — an estimated $1K sold.
New York State Common Retirement Fund first reported a position in SPPI in Q2 2013 and held it in 37 quarters. The position peaked at $2.31M in Q2 2018. 75 funds tracked by Wall St. Rank hold SPPI as of Q3 2022.
- New York State Common Retirement Fund reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2022 after selling out during the quarter.
- New York State Common Retirement Fund sold 1,065 Spectrum Pharmaceuticals Inc shares in Q3 2022, an estimated $1K.
- New York State Common Retirement Fund first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 37 quarters.
- New York State Common Retirement Fund's Spectrum Pharmaceuticals Inc position peaked at $2.31M in Q2 2018.
- 75 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2022.
Based on New York State Common Retirement Fund's 13F filing for Q3 2022, filed 8 Nov 2022.